These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 25997493)
1. Docosahexaenoic acid inhibits the growth of hormone-dependent prostate cancer cells by promoting the degradation of the androgen receptor. Hu Z; Qi H; Zhang R; Zhang K; Shi Z; Chang Y; Chen L; Esmaeili M; Baniahmad A; Hong W Mol Med Rep; 2015 Sep; 12(3):3769-3774. PubMed ID: 25997493 [TBL] [Abstract][Full Text] [Related]
2. The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats. Wang C; Luo F; Zhou Y; Du X; Shi J; Zhao X; Xu Y; Zhu Y; Hong W; Zhang J Exp Cell Res; 2016 Jul; 345(2):125-33. PubMed ID: 25849092 [TBL] [Abstract][Full Text] [Related]
3. Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Chung BH; Mitchell SH; Zhang JS; Young CY Carcinogenesis; 2001 Aug; 22(8):1201-6. PubMed ID: 11470750 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968 [TBL] [Abstract][Full Text] [Related]
5. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen. Weber H; Ruoff R; Garabedian MJ PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133 [TBL] [Abstract][Full Text] [Related]
6. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth. Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860 [TBL] [Abstract][Full Text] [Related]
8. Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo. Petiwala SM; Li G; Bosland MC; Lantvit DD; Petukhov PA; Johnson JJ Carcinogenesis; 2016 Aug; 37(8):827-838. PubMed ID: 27267997 [TBL] [Abstract][Full Text] [Related]
9. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
11. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
12. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells. Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518 [TBL] [Abstract][Full Text] [Related]
14. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer. Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058 [TBL] [Abstract][Full Text] [Related]
15. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice. Chisamore MJ; Gentile MA; Dillon GM; Baran M; Gambone C; Riley S; Schmidt A; Flores O; Wilkinson H; Alves SE J Steroid Biochem Mol Biol; 2016 Oct; 163():88-97. PubMed ID: 27106747 [TBL] [Abstract][Full Text] [Related]
16. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells. He ML; Yuan HQ; Jiang AL; Gong AY; Chen WW; Zhang PJ; Young CY; Zhang JY Cancer; 2006 Jun; 106(12):2547-55. PubMed ID: 16691616 [TBL] [Abstract][Full Text] [Related]
17. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Wang S; Wu J; Suburu J; Gu Z; Cai J; Axanova LS; Cramer SD; Thomas MJ; Perry DL; Edwards IJ; Mucci LA; Sinnott JA; Loda MF; Sui G; Berquin IM; Chen YQ Carcinogenesis; 2012 Feb; 33(2):404-12. PubMed ID: 22159221 [TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid differentially modulates the cell cycle and metabolism- related genes in tumor and pre-malignant prostate cells. Tamarindo GH; Góes RM Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158766. PubMed ID: 32712248 [TBL] [Abstract][Full Text] [Related]
19. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
20. 17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition. Lin Z; Peng R; Li Z; Wang Y; Lu C; Shen Y; Wang J; Shi G Int J Mol Med; 2015 Aug; 36(2):424-32. PubMed ID: 26059743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]